Journal Mobile Options
Table of Contents
Vol. 2, No. 4, 1999
Issue release date: June 2000
Community Genet 1999;2:173–178

Prevalence of Pedigrees Suggestive of Hereditary Nonpolyposis Colorectal Cancer among a Community Sample of Women Eligible for Screening Mammography

Ramsey S.D. · Freedman A.N. · Berry K. · Andersen M.R. · Urban N.
aDepartment of Medicine, University of Washington, bFred Hutchinson Cancer Research Center, Seattle, Wash., cNational Cancer Institute, Rockville, Md., dDepartment of Biostatistics, University of Washington, Seattle, Wash., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: To determine from a large cohort of women eligible for screening mammography, the number who would meet criteria for genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC). Methods: Detailed personal and family cancer histories, obtained from 6,682 women aged 50–80 years randomly selected from communities in Washington State, were matched to the Amsterdam criteria, Bethesda guidelines, and Japanese criteria for HNPCC. Results: One (0.015%) respondent met the Amsterdam criteria, 2 (0.035%) met the Japanese criteria and 5 (0.075%) met the Bethesda guidelines. Conclusion: Using the time of presentation for initial mammography as an opportunity to screen for HNPCC would detect very few families at high risk for this condition.

Copyright © 2000 S. Karger AG, Basel

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Bellacosa A, Genuardi M, Anti M, Viel A, Ponz de Leon M: Hereditary nonpolyposis colorectal cancer: Review of clinical, molecular genetics, and counseling aspects. Am J Med Genet 1996;62:353–364.
  2. Ponz de Leon M: Descriptive epidemiology of hereditary non-polyposis colorectal cancer. Tumori 1996;82:102–106.
  3. Aaltonen LA, Sankila R, Mecklin JP, Järvinen H, Pukkala E, Peltomaki P, de la Chapelle A: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev 1994;18:57–63.
  4. Houlston RS, Collins A, Slack J, Morton NE: Dominant genes for colorectal cancer are not rare. Ann Hum Genet 1992;56:99–103.
  5. Evans DG, Walsh S, Jeacock J, Robinson C, Hadfield L, Davies DR, Kingston R: Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1,137 consecutive cases of colorectal cancer. Br J Surg 1997;84:1281–1285.
  6. Lindor NM, Greene MH: The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998;90:1039–1071.
  7. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 1996;14:1730–1740.
  8. Vasen HF, Mecklin JP, Khan PM, Lynch HT: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424–425.
  9. Percesepe A, Anti M, Roncucci L, Armelao F, Marra G, Pahor M, Coco C, Gasbarrini G, Ponz de Leon M: The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancer. Br J Cancer 1995;72:1320–1323.
  10. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B, Kinzler KW: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169–174.

    External Resources

  11. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758–1762.
  12. Nakahara M, Yokozaki H, Yasui W, Dohi K, Tahara E: Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Cancer Epidemiol Biomarkers Prev 1997;6:1057–1064.
  13. Jarvinen HJ, Mecklin JP, Sistonen P: Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405–1411.
  14. Aaltonen LA, Salovaara R, Kristo P, Canzion F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen H, Jarvinen H, Mecklin JP, de la Chapelle A: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:1481–1487.
  15. Lynch HT, Smyrk TC: Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med 1998;338:1537–1538.
  16. Dunlop MG: The case for surveillance of ‘high-risk’ families. Eur J Gastroenterol Hepatol 1998;10:229–233.
  17. Stoddard AM, Rimer BK, Lane D, Fox SA, Lipkus I, Luckmann R, Avrunin JS, Sprachman S, Costanza M, Urban N: Underusers of mammogram screening: Stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium. Prev Med 1998;27:478–487.
  18. Research and Response, Incorporated. Seattle, Wash., USA.
  19. Modica S, Roncucci L, Benatti P, Gafa L, Tamassia MG, Dardanoni L, Ponz de Leon M: Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal cancer registries. Int J Cancer 1995;62:685–689.
  20. Westlake PJ, Bryant HE, Huchcroft SA, Sutherland LR: Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta. Dig Dis Sci 1991;36:1441–1447.
  21. Kee F, Collins BJ: How prevalent is cancer family syndrome? Gut 1991;32:509–512.
  22. Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A, Tops C, Moller P, Fodde R: Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998;339:511–518.
  23. Ponz de Leon M: Prevalence of hereditary nonpolyposis colorectal carcinoma (HNPCC). Ann Med 1994;26:209–214.

    External Resources

  24. Brown ML, Kessler LG: The use of gene tests to detect hereditary predisposition to cancer: Economic considerations. J Natl Cancer Inst 1995;87:1131–1136.
  25. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC: A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669–1674.
  26. Aitken J, Bain C, Ward M, Siskind V, MacLennan R: How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 1995;141:863–871.
  27. Kerber RA, Slattery ML: Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244–248.
  28. Love RR, Evans AM, Josten DM: The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985;38:289–293.
  29. Vasen HF, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, Offerhaus GJ, Meera-Khan P: Hereditary nonpolyposis colorectal cancer: Results of long-term surveillance in 50 families. Eur J Cancer 1995;31A:1145–1148.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50